Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
ISTH Webinar: Hemostatic Complications in Patients on ECMO and VADs
Tell a Friend About This EventTell a Friend
ISTH Webinar: Hemostatic Complications in Patients on ECMO and VADs

 Export to Your Calendar 8/8/2018
When: Wednesday, August 8, 2018
16:00 UTC

« Go to Upcoming Event List  



Hemostatic complications in patients on ECMO and VADs

 

August 8, 2018 16:00 - 17:00 UTC

(August 8 12:00 EDT)

ISTH Core Curriculum 16.3, 16.4, 23.4, 25.1, 27.3 and 27.4 

Speakers:

Jean Connors "Complications in adult patients"

Patricia Massicotte "Complications in pediatric patients"

 

Moderator: TBD

 

CLICK HERE TO SIGN IN AND REGISTER

 

Biographies

Jean Connors

Jean M Connors MD is a hematology attending at Brigham and Women’s Hospital and Dana Farber Cancer Institute, the Medical Director of the inpatient Hemostatic Antithrombotic Stewardship program and the outpatient Anticoagulation Management Services, and an associate professor of medicine at Harvard Medical School. She attended Johns Hopkins School of Medicine, did medical residency at Beth Israel Hospital Boston, and completed fellowship training in hematology-oncology at Brigham and Women’s Hospital and in transfusion medicine at the Harvard Joint Program in Transfusion Medicine. Dr. Connors has participated in numerous clinical trials for patients with venous thrombosis, is currently participating in the trials of reversal agents for the direct oral anticoagulants, and is the leading national level trials to study the use of DOAC in cancer associated venous thromboembolism. She works closely with the Hemostatic Antithrombotic Stewardship staff which is responsible for oversight and management of anticoagulation for patients with mechanical circulatory support.

Patricia Massicotte

Dr. Massicotte has a broad background in the research and clinical area of thrombophilia, including a fellowship with Drs Jack Hirsh, Jeff Weitz and Maureen Andrew at McMaster University, Departments of Internal Medicine and Pediatrics; and a Masters of Science in Health Research Methodology at McMaster University, Hamilton Canada. She was a sub investigator in the two multicentre, multinational randomized clinical trials in children investigating the safety and efficacy of low molecular weight heparin for thromboprophylaxis (PROTEKT) and treatment (REVIVE) in children and received a Pharmaceutical Manufacturing Association of Canada/Medical Research Council of Canada Joint Fellowship award to complete these studies . She is co author on the evidence based guidelines for management of thrombophilia in children; CHEST supplements 2004 and 2008. She is/has been involved in leadership roles in pediatric thrombosis including Chair of the Pediatric Perinatal Subcommittee of the International Society of Thrombosis and Hemostasis, co investigator with other major pediatric centers (research and clinical) in the submission of NIH grants and an organizer of the Gordon Conference for Mechanically Assisted Circulation. Her research and clinical interests have become more focused on the thromboprophylaxis of congenital heart disease and extracorporeal membranous oxygenation (ECLS). She was a sub investigator and co author of the antithrombotic therapy guidelines for the North American Berlin Heart IDE study and presented to the FDA device panel as part of the expert team. The NIH/NHLBI funded PumpKIN study invited her to be a member of the Protocol Development Committee as the Chair of the development of the antithrombotic therapy Guidelines. I am now currently a consultant and investigator on this project. In addition, she was an invited member of the NIH/NHLBI funded working groups “Thrombosis in Pediatric Cardiology and Congenital Heart Disease” and “Rethinking New Technologies to Facilitate Pediatric and Neonatal Clinical Trials in Hemostasis, Thrombosis, and Transfusion Medicine”, and the American Heart Association Guideline development group for Antithrombotic Therapy in Infants, Children and Young Adults with Congenital and Acquired Heart Disease. 

 

Supported by an unrestricted educational grant from Instrumentation Laboratory:

RELATED PRODUCTS
Sign-in to view related products »
Membership Management Software Powered by YourMembership  ::  Legal